New Champ Leaves Indelible Mark on Stock Challenge

We are now ready to unveil this month’s champion… In our mid-month recap, we forewarned members that biotech/pharma stocks were gearing up to be the Stock Challenge story of the month. The top two players in this month’s contest selected exclusively biotech/pharma stocks, with those picks combining for an average of roughly 82% returns in […]

Read More…

Surprise Sector Could Sweep This Month’s Podium

It has been a rocky start to the month. The Stock Challenge Index (SCI) is down almost 6%; and, only about a third of the selected stocks are reporting gains so far. The Stock Challenge Index Biotech/pharma stocks are the brewing story of the month. The top 2 performing stocks (with an average of approximately […]

Read More…

Entheon Biomedical Corp. Announces DTC Eligibility

Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the United States. The DTC is the largest […]

Read More…